ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 157 filers reported holding ASCENDIS PHARMA A/S in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $33,137,000 | +2018.7% | 251,900 | +1713.7% | 8.24% | +1472.1% |
Q1 2020 | $1,564,000 | -85.3% | 13,889 | -84.6% | 0.52% | -81.7% |
Q1 2019 | $10,631,000 | +370.2% | 90,325 | -19.7% | 2.87% | +84.1% |
Q3 2016 | $2,261,000 | -15.9% | 112,497 | -44.5% | 1.56% | +13.5% |
Q2 2016 | $2,687,000 | -22.6% | 202,520 | +8.2% | 1.37% | +8.0% |
Q1 2016 | $3,473,000 | -33.4% | 187,220 | -34.3% | 1.27% | -45.0% |
Q4 2015 | $5,217,000 | +9.3% | 284,785 | +5.6% | 2.31% | -29.4% |
Q3 2015 | $4,775,000 | +33.3% | 269,785 | +33.2% | 3.27% | +85.0% |
Q2 2015 | $3,581,000 | – | 202,525 | – | 1.77% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 7,387,900 | $1,177,557,000 | 16.32% |
Q Global Advisors, LLC | 66,714 | $10,634,000 | 8.85% |
Ghost Tree Capital, LLC | 120,000 | $19,127,000 | 5.59% |
Vivo Capital, LLC | 760,606 | $121,233,000 | 5.44% |
Spyglass Capital Management LLC | 1,378,887 | $219,781,000 | 5.04% |
Avoro Capital Advisors LLC | 1,980,000 | $315,592,000 | 4.96% |
Eversept Partners, LP | 445,203 | $70,960,906 | 4.93% |
Sofinnova Investments, Inc. | 499,824 | $79,667,000 | 4.72% |
Eventide Asset Management | 1,748,648 | $278,717,000 | 3.68% |
Baker Brothers Advisors | 4,541,604 | $723,886,000 | 3.18% |